Ivermectin has New Application in Inhibiting Colorectal Cancer Cell Growth
Colorectal cancer (CRC) is the third most common cancer worldwide and still lacks effective therapy. Ivermectin, an antiparasitic drug, has been shown to possess anti-inflammation, anti-virus, and antitumor properties. However, whether ivermectin affects CRC is still unclear. The objective of this s...
Saved in:
Main Authors: | Shican Zhou (Author), Hang Wu (Author), Wenjuan Ning (Author), Xiao Wu (Author), Xiaoxiao Xu (Author), Yuanqiao Ma (Author), Xingwang Li (Author), Junhong Hu (Author), Chenyu Wang (Author), Junpeng Wang (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Novel Ivermectin-Derived Compound D4 and Its Antimicrobial/Biofilm Properties against MRSA
by: Xinyi Tan, et al.
Published: (2021) -
Decylubiquinone Inhibits Colorectal Cancer Growth Through Upregulating Sirtuin2
by: Jinlian Li, et al.
Published: (2022) -
SHP2 inhibition improves celastrol-induced growth suppression of colorectal cancer
by: Linxi Zhang, et al.
Published: (2022) -
Is Ivermectin Effective in Treating COVID-19?
by: Shuangshuang Yang, et al.
Published: (2022) -
Antisense Oligonucleotides against miR-21 Inhibit the Growth and Metastasis of Colorectal Carcinoma via the DUSP8 Pathway
by: Tao Ding, et al.
Published: (2018)